AM Armbrecht, PA Aspinall, B Dhillon - British Journal of Ophthalmology, 2004 - bjo.bmj.com Methods: 48 of 51 recruited patients with predominantly classic subfoveal
choroidal neovascularisation (CNV) secondary AMD who were treated with PDT were
followed up for 1 year. Assessment included distance and near visual ... Cited by 31 - Related articles - BL Direct - All 9 versions
- ►iovs.org M Varano, V Parisi, M Tedeschi, M Sciamanna, … - Investigative ophthalmology & visual science, 2005 - ARVO RESULTS. At 15 days after PDT, myopic CNV eyes showed, in relation to baseline
values, a significant (ANOVA, P < 0.01) reduction in the diameter of the lesion
that correlated (Pearson test, P < 0.01) with the significant (ANOVA, P < ... Cited by 21 - Related articles - All 6 versions
MB Parodi, S Da Pozzo, G Ravalico - Acta Ophthalmol Scand, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 14 - Related articles - BL Direct - All 3 versions
F Bandello, P Lanzetta, M Battaglia Parodi, … - Graefe's Archive for Clinical and Experimental …, 2003 - Springer Abstract Background: Photodynamic therapy with verteporfin (Visudyne; Novartis,
Bülach, Switzerland) has been proposed for the treatment of subfoveal choroidal
neovasculariza- tion secondary to pathologic myopia. We retrospectively ... Cited by 7 - Related articles - BL Direct - All 3 versions
NA Dewi, M Yuzawa, K Tochigi, A Kawamura, … - Japanese Journal of Ophthalmology, 2008 - Springer Macular Degeneration with Photodynamic Therapy (TAP) investigation,AMD treatment
with verteporfin PDT results in early closure of CNV, with reductions in macular
edema and exudation, leading to stabilization and even limited improvements ... Cited by 2 - Related articles - All 2 versions
MB Parodi - American Journal of Ophthalmology, 2003 - Elsevier The authors describe the clinicopathologic findings in eight cases with
surgically removed choroidal neovascularization (CNV) after photodynamic therapy
(PDT) with verteporfin. The article reports histologic analyses of CNVs of ... Cited by 2 - Related articles - All 5 versions
A Iriyama, R Obata, Y Inoue, H Takahashi, Y … - Graefe's Archive for Clinical and Experimental …, 2008 - Springer Abstract Purpose To evaluate the effect of posterior juxtascleral triamcinolone
acetonide (TA) injection combined with photodynamic therapy with verteporfin
(PDT) for treating exudative age-related macular degeneration (AMD), the ... Cited by 4 - Related articles - BL Direct - All 2 versions
P Lanzetta, M Battaglia Parodi, M Ambesi- … - Graefe's Archive for Clinical and Experimental …, 2004 - Springer Abstract Background: Photodynam- ic therapy is a relatively new modal- ity for
the treatment of subfoveal choroidal neovascularization (CNV). An unusual
response to verteporfin therapy of myopic CNVs is reported. Methods: Out of ... Cited by 3 - Related articles - BL Direct - All 3 versions
SCN as a Prognostic - pdf.medrang.co.kr Pathologic myopia is a major cause of legal blindness in developed countries.1-2
The most common complication leading to decreased central vision in pathologic
myopia is choroidal neovascularization (CNV), which affects 5% to 10% of ... Related articles - View as HTML
MB Parodi, P Iacono, G Ravalico - British Journal of Ophthalmology, 2009 - bjo.bmj.com Results: CNV at baseline showed a high FAF signal with uniform distribution, or
with some spots of low FAF internally, in 64% and 36% of cases, respectively. At
the 3-month control after PDT, the CNV retained the same response, but a ... Related articles - All 3 versions
